Wang M - Search Results

1

Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer.

Rancourt C, Rogers BE, Sosnowski BA, Wang M, Piché A, Pierce GF, Alvarez RD, Siegal GP, Douglas JT, Curiel DT. Rancourt C, et al. Among authors: wang m. Clin Cancer Res. 1998 Oct;4(10):2455-61. Clin Cancer Res. 1998. PMID: 9796978

2

Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma.

Rosenfeld ME, Wang M, Siegal GP, Alvarez RD, Mikheeva G, Krasnykh V, Curiel DT. Rosenfeld ME, et al. Among authors: wang m. J Mol Med (Berl). 1996 Aug;74(8):455-62. doi: 10.1007/BF00217521. J Mol Med (Berl). 1996. PMID: 8872859

3

Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.

Deshane J, Siegal GP, Wang M, Wright M, Bucy RP, Alvarez RD, Curiel DT. Deshane J, et al. Among authors: wang m. Gynecol Oncol. 1997 Mar;64(3):378-85. doi: 10.1006/gyno.1996.4566. Gynecol Oncol. 1997. PMID: 9062138

4

Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.

Rosenfeld ME, Vickers SM, Raben D, Wang M, Sampson L, Feng M, Jaffee E, Curiel DT. Rosenfeld ME, et al. Among authors: wang m. Ann Surg. 1997 May;225(5):609-18; discussion 618-20. doi: 10.1097/00000658-199705000-00017. Ann Surg. 1997. PMID: 9193188 Free PMC article.

5

Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary.

Rancourt C, Robertson MW 3rd, Wang M, Goldman CK, Kelly JF, Alvarez RD, Siegal GP, Curiel DT. Rancourt C, et al. Among authors: wang m. Clin Cancer Res. 1998 Feb;4(2):265-70. Clin Cancer Res. 1998. PMID: 9516909

6

Gene therapy for ovarian carcinoma.

Robertson MW 3rd, Barnes MN, Rancourt C, Wang M, Grim J, Alvarez RD, Siegal GP, Curiel DT. Robertson MW 3rd, et al. Among authors: wang m. Semin Oncol. 1998 Jun;25(3):397-406. Semin Oncol. 1998. PMID: 9633852 Review.

7

Use of a tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cells.

Robertson MW 3rd, Wang M, Siegal GP, Rosenfeld M, Ashford RS 2nd, Alvarez RD, Garver RI, Curiel DT. Robertson MW 3rd, et al. Among authors: wang m. Cancer Gene Ther. 1998 Sep-Oct;5(5):331-6. Cancer Gene Ther. 1998. PMID: 9824053

8

High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector.

Wang M, Rancourt C, Navarro JG, Krisky D, Marconi P, Oligino T, Alvarez RD, Siegal GP, Glorioso JC, Curiel DT. Wang M, et al. Gynecol Oncol. 1998 Nov;71(2):278-87. doi: 10.1006/gyno.1998.5132. Gynecol Oncol. 1998. PMID: 9826472

9

Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.

Rancourt C, Piché A, Gomez-Navarro J, Wang M, Alvarez RD, Siegal GP, Fuller GM, Jones SA, Curiel DT. Rancourt C, et al. Among authors: wang m. Clin Cancer Res. 1999 Jan;5(1):43-50. Clin Cancer Res. 1999. PMID: 9918201

10

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches.

Vanderkwaak TJ, Wang M, Gómez-Navarro J, Rancourt C, Dmitriev I, Krasnykh V, Barnes M, Siegal GP, Alvarez R, Curiel DT. Vanderkwaak TJ, et al. Among authors: wang m. Gynecol Oncol. 1999 Aug;74(2):227-34. doi: 10.1006/gyno.1999.5432. Gynecol Oncol. 1999. PMID: 10419736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68,299 results

Search Page

Filters